Baxter Recalls Dose IQ Software for Defect Impacting Drug Delivery

Serious injuries or death may result from the use of these devices. The FDA has identified this as a Class I recall, the most serious type o

If your email program has trouble displaying this email, view as a webpage. Baxter Healthcare Recalls Dose IQ Software Version 9.0.x, Used with Spectrum IQ Infusion Pumps, for Software Defect That May Improperly Configure Drug and Fluid Delivery Baxter Healthcare is recalling the Dose IQ Safety Software used with the Spectrum IQ Infusion System. A software defect may lead to mismatched drug information in drug libraries created using version 9.0.x of the computer-based software. If drug mismatch occurs, this may lead to serious adverse events including delay in therapy, under-infusion, or over-infusion of medication. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Read More Questions? If you have questions about this recall, should contact Baxter's Technical Assistance at 1-800-356-3454 and select Prompt 1.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA